Equillium (EQ) Retained Earnings (2017 - 2026)
Equillium (EQ) reported Retained Earnings of $370000.0 for Q1 2026, down 49.38% year-over-year from $731000.0 in Q1 2025, and up 100.17% quarter-over-quarter from -$216.2 million in Q4 2025.
Equillium (EQ) Retained Earnings (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Retained Earnings data on file, last reported at $370000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at $370000.0, down 49.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $370000.0 (down 49.38% YoY), and the FY2025 annual result was -$216.2 million, down 27783.1% from the prior year.
- Retained Earnings improved to $370000.0 in Q1 2026 per EQ's latest filing, from -$216.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at $781000.0 in Q4 2024 and troughed at -$216.2 million in Q4 2025.
- A 5-year average of -$58.6 million and a median of $140000.0 in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 457.86% in 2024, then sank 83048.21% in 2025.
- A 5-year view of Retained Earnings shows it stood at $76000.0 in 2022, then surged by 84.21% to $140000.0 in 2023, then soared by 457.86% to $781000.0 in 2024, then slumped by 27783.1% to -$216.2 million in 2025, then jumped by 100.17% to $370000.0 in 2026.
- Business Quant data shows EQ's Retained Earnings at $370000.0 in Q1 2026, -$216.2 million in Q4 2025, and -$212.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 370,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 370,000.00 |
| Dec 31, 2025 | -216.21 Mn |
| Sep 30, 2025 | -212.43 Mn |
| Jun 30, 2025 | -208.20 Mn |
| Mar 31, 2025 | 731,000.00 |
| Dec 31, 2024 | 781,000.00 |
| Sep 30, 2024 | -188.01 Mn |
| Jun 30, 2024 | 251,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Sep 30, 2023 | 458,000.00 |
| Jun 30, 2023 | 340,000.00 |
| Mar 31, 2023 | 305,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Sep 30, 2022 | -175.18 Mn |
| Jun 30, 2022 | -149,000.00 |
| Mar 31, 2022 | -454,000.00 |
| Dec 31, 2021 | -138,000.00 |
| Sep 30, 2021 | -99.36 Mn |
| Jun 30, 2021 | -209,000.00 |